Swiss Re’s Lam Research LRCX Stock Holding History

Swiss Re’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.77M	Buy	4,095 +3,448	+533%	+$1.05M	0.16%	13
2026 Q1	$138K	Hold	647	–	–	0.84%	14
2025 Q4	$111K	Buy	+647	New	+$101K	0.01%	17

Other funds holding LRCX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Swiss Re's LRCX Position: Q2 2026 in Review

Swiss Re increased its Lam Research (LRCX) stake by 533% in Q2 2026, buying an estimated $1.05M and bringing the position to 4,095 shares worth $1.77M. The position accounts for 0.16% of the portfolio, ranked #13.

Swiss Re first reported a position in LRCX in Q4 2025 and has held it in 3 quarters since. 3,125 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

Swiss Re held 4,095 shares of Lam Research worth $1.77M as of Q2 2026.
Swiss Re bought 3,448 Lam Research shares in Q2 2026, an estimated $1.05M.
Lam Research made up 0.16% of Swiss Re's portfolio in Q2 2026, its #13 holding.
Swiss Re first reported a position in Lam Research in Q4 2025 and has held it in 3 quarters since.
3,125 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Swiss Re's 13F filing for Q2 2026, filed 11 Aug 2026.